Global Oncology Market Outlook, 2029

The global oncology information systems (OIS) market is expected to experience significant growth. This growth is attributed to several factors, including an aging population, increasing adoption of technologically advanced treatments, and a growing emphasis on data-driven healthcare. A major driver of the OIS market is the alarming rise in cancer cases worldwide. This surge in cancer diagnoses necessitates efficient management of patient data and treatment plans, which OIS effectively facilitates. The growing adoption of technologically advanced treatments for cancer is propelling the OIS market forward. These advancements often generate vast amounts of complex data, requiring robust OIS solutions for organization, analysis, and utilization in treatment planning. Additionally, OIS plays a crucial role in streamlining workflows and reducing medical errors, ultimately improving the quality of care delivered to cancer patients. The financial burden of cancer care is another factor driving the OIS market. OIS solutions offer the potential to manage costs associated with cancer treatment by enabling healthcare providers to optimize treatment plans, minimize redundancies, and potentially reduce hospital stays. For instance, features like treatment planning systems and clinical decision support systems within OIS can guide physicians towards more targeted and effective therapies, potentially leading to reduced healthcare costs. The OIS market also faces certain challenges. Concerns regarding data privacy and security in the healthcare industry pose a significant hurdle. The increasing number of cyberattacks targeting healthcare organizations necessitates robust security measures within OIS platforms to ensure patient data remains confidential. Additionally, a lack of skilled IT professionals in the healthcare sector can hinder the implementation and effective utilization of OIS solutions.

According to the research report, “Global oncology information systems market Outlook, 2029” published by Bonafide Research, the market is anticipated to cross USD 12 Billion by 2029. Despite these challenges, the future of the OIS market appears promising. Advancements in artificial intelligence (AI) and machine learning (ML) hold immense potential for enhancing the capabilities of OIS. By leveraging these technologies, OIS can be equipped to provide more accurate treatment predictions, personalize treatment plans for individual patients, and improve overall treatment outcomes. The global oncology information systems market is poised for significant growth in the coming years. Rising cancer prevalence, advancements in cancer treatment, and the potential for cost optimization are fueling market expansion. While data security concerns and a shortage of skilled IT professionals pose challenges, continuous innovation in AI and ML promises to unlock new possibilities for OIS, ultimately leading to improved cancer care delivery.

Market Trends

• Growing Adoption of Advanced Treatment Technologies: The increasing use of complex cancer treatments, such as targeted therapies and immunotherapy, generates vast amounts of data. OIS solutions are becoming indispensable for managing this data deluge, facilitating its analysis and utilization in personalized treatment planning.
• Focus on Data-Driven Healthcare: The healthcare industry's growing emphasis on data-driven decision-making is fueling the demand for OIS. These systems enable healthcare providers to leverage patient data for improved clinical decision-making, ultimately leading to better patient outcomes.
• Integration with Artificial Intelligence (AI) and Machine Learning (ML): Advancements in AI and ML are revolutionizing the OIS landscape. Integration of these technologies empowers OIS to provide more accurate treatment predictions, personalize treatment plans for individual patients, and potentially optimize treatment efficacy.

Market Challenges



• Data Privacy and Security Concerns: The ever-present threat of cyberattacks on healthcare organizations necessitates robust security measures within OIS platforms. Stringent data privacy regulations further complicate the landscape, requiring OIS vendors to ensure patient data remains confidential while complying with evolving legal frameworks.
• Limited Availability of Skilled IT Professionals: The implementation and effective utilization of OIS solutions hinge on the availability of skilled IT professionals within healthcare institutions. However, a current shortage of such professionals can hinder the widespread adoption and optimal use of OIS across the healthcare sector.
• High Implementation and Maintenance Costs: The initial investment required for OIS implementation, coupled with ongoing maintenance costs, can be a significant hurdle for some healthcare providers, particularly in resource-constrained settings.

Market Drivers

• Rising Prevalence of Cancer: The alarming global increase in cancer cases is a primary driver of the OIS market. As the number of cancer patients grows, the demand for efficient data management and optimized treatment plans necessitates the adoption of robust OIS solutions.
• Focus on Cost Optimization in Cancer Care: The financial burden of cancer treatment is a major concern for both patients and healthcare systems. OIS offers the potential to manage these costs by streamlining workflows, minimizing redundancies, and potentially reducing hospital stays through optimized treatment plans.
• Increasing Government Initiatives for Healthcare IT Adoption: Government bodies in many countries are actively promoting the adoption of healthcare IT solutions, including OIS. These initiatives, often coupled with funding programs, are accelerating the growth of the OIS market in specific regions.

Based on the report the product type is segmented into Software and hardware. The Software is leading in the oncology information system industry due to its ability to integrate, streamline, and enhance the efficiency of oncology care through comprehensive data management, advanced analytics, and personalized treatment planning.

The oncology information system (OIS) industry has witnessed significant growth and transformation, primarily driven by the advancements in software technology. Software solutions in oncology offer a multifaceted approach to managing the complex landscape of cancer treatment, encompassing patient data management, treatment planning, clinical decision support, and research analytics. This digital evolution is reshaping oncology care by addressing several critical aspects. The integration capabilities of oncology software are pivotal. These systems can seamlessly connect various departments within a healthcare institution, from radiology and pathology to surgical and medical oncology. This interoperability ensures that all relevant patient data, including diagnostic images, pathology reports, and treatment histories, are accessible in a centralized repository. Such comprehensive data integration eliminates information silos, facilitating more informed clinical decisions and fostering a collaborative treatment environment. The ability to streamline workflows cannot be understated. Oncology software automates many administrative and clinical processes, reducing the burden on healthcare professionals. From appointment scheduling and billing to documenting patient encounters and managing treatment protocols, these systems enhance operational efficiency. This automation not only saves time but also minimizes the risk of human errors, thereby improving patient safety and the overall quality of care. Another significant advantage of oncology software is its capability to provide advanced analytics and decision support. Modern OIS platforms are equipped with sophisticated algorithms and machine learning tools that analyse vast amounts of data to identify patterns and predict outcomes. These insights can help oncologists tailor treatment plans to individual patients, considering their unique genetic, environmental, and lifestyle factors. Personalized treatment plans are crucial in oncology, as they increase the likelihood of successful outcomes and minimize adverse effects. In addition, oncology software supports comprehensive treatment planning. Radiation therapy, for instance, requires precise calculations and simulations to target cancerous cells while sparing healthy tissues. OIS platforms offer advanced tools for creating and optimizing radiation therapy plans, ensuring high accuracy and effectiveness. These tools often incorporate 3D imaging and dosimeter, providing detailed visualizations and calculations that are essential for effective treatment. The role of software in research and clinical trials is also noteworthy. Oncology software facilitates the collection and analysis of clinical trial data, accelerating the development of new treatments and therapies. Researchers can access real-time data on patient responses, side effects, and outcomes, enabling them to make quicker adjustments and improvements. This capability is particularly important in oncology, where rapid advancements in understanding and treating cancer are crucial for patient survival and quality of life. Patient engagement and education are significantly enhanced through oncology software. Patient portals and mobile applications allow patients to access their medical records, treatment plans, and educational resources.

Based on the report, the end user segment is segmented into Hospitals, research centres and speciality Clinics. Hospitals lead the oncology information system industry due to their comprehensive and centralized role in cancer treatment, encompassing a wide range of services from diagnosis to therapy, which requires sophisticated and integrated information management solutions to ensure high-quality patient care.<\b>

Hospitals play a pivotal role in the oncology information system (OIS) industry, emerging as the primary end-users due to their multifaceted responsibilities in cancer care. The centralization and comprehensiveness of services provided by hospitals necessitate advanced information systems to manage the complexities of oncology treatment effectively. This leadership is driven by several critical factors that underline the indispensable need for sophisticated OIS in hospital settings. Hospitals serve as the primary points of entry for cancer diagnosis and treatment, catering to a diverse patient population. This central role means that hospitals handle a vast array of diagnostic procedures, including imaging, biopsies, and laboratory tests. An effective OIS integrates these diagnostic data, providing a unified platform for oncologists to access comprehensive patient information. This integration ensures that all relevant data, from initial diagnosis through the continuum of care, are readily available, facilitating accurate and timely clinical decisions. Hospitals offer a full spectrum of oncology services, including surgery, chemotherapy, radiation therapy, and palliative care. Managing these diverse treatment modalities requires a robust information system capable of coordinating complex workflows and protocols. OIS platforms in hospitals streamline these processes by automating scheduling, treatment planning, and patient monitoring. This automation not only enhances operational efficiency but also reduces the risk of errors, ensuring that patients receive the correct treatments at the appropriate times. Another significant factor is the multidisciplinary nature of cancer care in hospitals. Oncology treatment often involves a team of specialists, including medical oncologists, radiation oncologists, surgeons, pathologists, and supportive care providers. OIS enables seamless communication and collaboration among these professionals by providing a centralized repository of patient information. This collaboration is crucial for developing and executing personalized treatment plans, as it ensures that all team members are informed and coordinated, leading to improved patient outcomes. Hospitals are also at the forefront of clinical research and trials, which are essential for advancing cancer treatment. Many hospitals are affiliated with research centers and academic institutions, conducting cutting-edge research to develop new therapies. OIS platforms support these research activities by efficiently managing clinical trial data, patient recruitment, and regulatory compliance. By integrating clinical and research data, hospitals can accelerate the translation of research findings into clinical practice, offering patients access to the latest treatments and innovations.

North America leads the oncology information system industry due to its advanced healthcare infrastructure, significant investments in healthcare technology, a high prevalence of cancer, and strong emphasis on research and development, which collectively drive the adoption and innovation of comprehensive oncology information systems.

North America's dominance in the oncology information system (OIS) industry can be attributed to a combination of factors that create an environment conducive to the adoption and advancement of these sophisticated systems. The region's well-established healthcare infrastructure, substantial investments in healthcare technology, high prevalence of cancer, and robust research and development activities are key elements that underpin its leadership in this sector. North America, particularly the United States and Canada, boasts some of the most advanced healthcare infrastructures in the world. This includes state-of-the-art hospitals, cancer treatment centers, and academic institutions equipped with cutting-edge technology. The existence of such a robust healthcare framework provides a solid foundation for the integration and utilization of advanced OIS. These systems are crucial for managing the complexities of cancer treatment, which involves multiple modalities such as surgery, chemotherapy, radiation therapy, and immunotherapy. The sophisticated infrastructure in North America ensures that healthcare providers have the necessary tools and facilities to implement and maximize the benefits of OIS. There is a significant level of investment in healthcare technology across North America. Governments, private sectors, and academic institutions invest heavily in health IT to improve patient outcomes, enhance operational efficiency, and reduce healthcare costs. Such investments are crucial for the development and deployment of advanced OIS. These systems require substantial financial resources for research, development, implementation, and maintenance. The financial commitment seen in North America ensures continuous innovation and improvement in OIS technologies, keeping them at the forefront of global advancements. The high prevalence of cancer in North America also drives the demand for advanced OIS. The region faces a considerable cancer burden, with high incidence and prevalence rates. According to the American Cancer Society, cancer is one of the leading causes of death in the United States, necessitating efficient and effective management systems to handle the large number of cases. OIS are critical in managing patient data, treatment planning, and follow-up care, ensuring that patients receive timely and personalized treatment. The pressing need to address this health challenge stimulates the adoption of sophisticated information systems that can streamline workflows and improve patient care outcomes. North America has a strong emphasis on research and development, particularly in the field of oncology. The region is home to numerous leading cancer research institutions and universities that conduct groundbreaking research in cancer biology, treatment, and care. These institutions often collaborate with technology companies to develop innovative OIS solutions. The synergy between academic research and technological innovation fosters the creation of advanced systems that incorporate the latest scientific discoveries and clinical practices. This focus on R&D ensures that OIS in North America remain at the cutting edge, incorporating the most recent advancements in oncology care. Regulatory frameworks and policies in North America support the adoption and implementation of health IT solutions, including OIS. For instance, initiatives such as the Health Information Technology for Economic and Clinical Health (HITECH) Act in the United States have incentivized healthcare providers to adopt electronic health records and other health IT systems. These policies create a favorable environment for the widespread adoption of OIS by providing financial incentives and setting standards for interoperability and data security.

• In August 2021 Germany, Siemens Healthineers acquired Varian Medical Systems (UK). This strategic move aimed to create a comprehensive and integrated portfolio of OIS solutions, potentially streamlining workflow across the cancer care continuum.
• In June 2021, Koninklijke Philips N.V. (Netherlands) partnered with Elekta (Sweden) to develop advanced OIS solutions. This collaboration focused on precision oncology, aiming to deliver more personalized and effective cancer care through data-driven insights.
• In December 2020, McKesson Corporation (US) launched McKesson Corporation's Ontada. This platform signifies the company's dedication to advancing cancer research and care. Ontada likely utilizes OIS technology to aggregate and analyze cancer data, potentially providing valuable insights for researchers and clinicians.

Considered in this report
• Historic year: 2018
• Base year: 2023
• Estimated year: 2024
• Forecast year: 2029

Aspects covered in this report
• Oncology Information System market Outlook with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Software
• Services

By Application
• Medical Oncology
• Radiation Oncology
• Surgical Oncology

By End User
• Hospitals
• Research Centers
• Specialty Clinics

The approach of the report:
This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience
This report can be useful to industry consultants, manufacturers, suppliers, associations, and organizations related to the Oncology Information System industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.